Economic TimesLean R·
Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?
Shares of Dr Lal PathLabs jumped nearly 8% on Monday to hit a new 52-week high after the diagnostics firm reported better-than-expected earnings for the first quarter of FY27, with multiple brokerages raising target prices.Dr Lal PathLabs shares jumped to a fresh 52-week high of Rs 1,895 apiece on Monday, rising more than 12% in just two sessions. The stock is on track to record its sharpest single-day surge since early May this year.The company on Friday reported a 28% year-on-year (YoY) incre…
Read at Economic Times →
